Device Knees

Triathlon

Payments companies reported to CMS as associated with Triathlon. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$16Massociated payments (2023-2025)
4,804clinicians with associated payments
1company reporting

By year

2023 $12M
2024 $2.3M
2025 $2.0M

Payments reported as associated with Triathlon, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $8.8M
Adult Reconstructive Orthopaedic Surgery $6.8M
Sports Medicine (Orthopaedic Surgery) $139K
Physician Assistant $59K
Orthopaedic Trauma $31K
Surgical $26K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Triathlon

These are the largest totals companies reported as associated with Triathlon. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Ormonde Mahoney Athens, GA Orthopaedic Surgery $1,594,735.16
Michael Mont Baltimore, MD Adult Reconstructive Orthopaedic Surgery $1,285,679.11
Viktor Krebs Cleveland, OH Adult Reconstructive Orthopaedic Surgery $1,236,989.12
Robert Barrack Saint Louis, MO Adult Reconstructive Orthopaedic Surgery $1,190,550.30
William Hozack Bensalem, PA Orthopaedic Surgery $1,187,716.72
William Maloney Stanford, CA Adult Reconstructive Orthopaedic Surgery $1,011,050.12
Arthur Malkani Louisville, KY Orthopaedic Surgery $974,650.12
Michael Masini Ypsilanti, MI Adult Reconstructive Orthopaedic Surgery $972,801.95
John Healey New York, NY Orthopaedic Surgery $506,945.41
Kirby Hitt Temple, TX Orthopaedic Surgery $480,944.52

Prescribed Triathlon?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.